-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Earnings Per Share, Diluted history and change rate from Q2 2010 to Q2 2025.
- Vitro Biopharma, Inc. Earnings Per Share, Diluted for the quarter ending 31 Jul 2025 was -0.38 USD/shares, a 1167% decline year-over-year.
- Vitro Biopharma, Inc. Earnings Per Share, Diluted for the twelve months ending 31 Jul 2025 was -1 USD/shares, a 17.4% increase year-over-year.
- Vitro Biopharma, Inc. annual Earnings Per Share, Diluted for 2024 was -2.21 USD/shares, a 82.6% decline from 2023.
- Vitro Biopharma, Inc. annual Earnings Per Share, Diluted for 2023 was -1.21 USD/shares, a 35.3% increase from 2022.
- Vitro Biopharma, Inc. annual Earnings Per Share, Diluted for 2022 was -1.87 USD/shares.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)